Janssen Pharmaceutica

Janssen Pharmaceutica

A pharmaceutical company that is in partnership with Johnson & Johnson. It is based in Beerse, Belgium and was founded in 1953.

Company

Janssen Pharmaceutica develops treatment for patients worldwide in the following therapeutic areas of healthcare: Cardiovascular & Metabolism , Immunology , Infectious Diseases & Vaccines , Neuroscience , Oncology and Pulmonary Hypertension. Janssen partners with academic researchers, governments, patient groups, healthcare professionals, and others in their research. Janssen's activities range from initial basic research and production to commercial and support services and sale of medicines. Janssen Pharmaceutica operates as a subsidiary of Johnson & Johnson.

COVID-19

Janssen Pharmaceutica has been working with its parent company to create a medicine to aid with the COVID-19 pandemic. It is using non-replicating viral vector as well as Ad26 (alone or with modified vaccina Ankara boost) technology to conduct studies on how the vaccine can be used in the pandemic.

Timeline

People

Name
Role
LinkedIn

Ai Hua Ong

Company Group Chairman, Asia Pacific

Elizabeth Blackwood

Vice President and Chief Quality Officer, Pharmaceuticals

Elizabeth Forminard

General Counsel, Pharmaceuticals

Jane Griffiths, Ph.D.

Global Head, Actelion

Jeff Steinhorn

Chief Information Officer, Pharmaceuticals, Head of Enterprise Functions, Johnson & Johnson Technology

Jennifer Taubert

Executive Vice President Worldwide Chairman, Pharmaceuticals Johnson & Johnson

Joaquin Duato

Vice Chairman of the Executive Committee Johnson & Johnson

Kris Sterkens

Company Group Chairman, Europe, Middle East, and Africa

Kristen Mulholland

Head of Human Resources, Global, Pharmaceuticals Group and External Innovation

Linda Fedow

Global Lead, Pharmaceutical Communication & Public Affairs

Mathai Mammen, M.D., Ph.D.

Global Head, Research and Development

Patrick Verheyen

Global Head, Janssen Business Development

Paul Stoffels M.D.

Vice Chairman of the Executive Committee, Chief Scientific Officer Johnson & Johnson

Pete Batesko

Vice President, Group Finance, Pharmaceuticals

Remo Colarusso

Vice President, Janssen Supply Chain

Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development & Supply, Jannsen Research & Development

Scott White

Company Group Chairman, North America Pharmaceuticals, Johnson & Johnson

Stef Heylen, M.D.

Chief Operating Officer, Development, Janssen Research & Development

Tom Heyman

Chief Executive Officer

Vanessa Broadhurst

Chief Operating Officer, Development

Further reading

Title
Author
Link
Type
Date

How one pharmaceutical company is reinventing the clinical trial - STAT

Andreas Koester

Web

September 21, 2018

Janssen Pharmaceutical Companies Expands R&D at San Francisco, California Campus - Area Development

Area Development News Desk

Web

January 13, 2020

Documentaries, videos and podcasts

Title
Date
Link

2019 Dr. Paul Janssen Award Celebration

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.